Quiet doesn’t mean small, it means focused. Surgical Automations, the Dallas-based stealth-mode startup aiming to redefine GI surgery, just closed an oversubscribed $3.4M seed round, announced Oct 30, 2025. Founded in 2023 by Dr. Sanket Chauhan, this team isn’t tinkering with tech, they’re teaching machines to navigate the human body with the precision of a top-tier surgeon and the calm of an AI that never blinks.
This $3.4M round was co-led by Dr. Fred Moll, the man who gave the world the da Vinci Surgical System and made robotic surgery a medical standard, and TurboStart, the Bengaluru VC founded by Ganesh Raju that’s been quietly bridging deep-tech founders with global capital before “cross-border” became a buzzword. When the father of surgical robotics and a VC with 52 startups in its portfolio back you, that’s not luck, it’s legacy aligning with ambition.
Dr. Sanket Chauhan saw the problem up close: colonoscopy and endoscopy remain inconsistent, painful, and underserved despite being frontline defenses against colorectal cancer, the 2nd leading cause of cancer deaths worldwide. So, during the pandemic, he started building an autonomous system to automate the hardest parts of these procedures. With an M.D., an MBA from SMU, and two surgical simulation fellowships, including one with the Dept. of Defense, he turned insight into invention. Beside him stands Co-Founder & COO Ritambhara Chauhan, an attorney with an LL.M. from UC Berkeley, an MBA from IIM Lucknow, and a résumé that bridges law, IP, and operational strategy like few others in medtech. Add Co-Founder Jason Blackstone, IP strategist and patent attorney, and Founding Engineer Bharadwaj Chukkala, a robotics mind from the Univ. of Maryland, and you’ve got a founding team fluent in code, compliance, and clinical nuance.
Their creation, the Vāsuki Robotic System, draws its name from Hindu mythology’s divine serpent, fitting for a machine designed to maneuver the GI tract with fluid precision. Powered by AI-based Automated Robotic Endoluminal Navigation (AREN), Vāsuki merges robotics, sensing, and deep learning models like Faster RCNN, ResNet, U-Net, and PolypNet. It’s built to automate the tedious, error-prone parts of endoscopy while keeping physicians firmly in control. Less fatigue. More consistency. Fewer lives lost to preventable diagnostic misses.
With the GI endoscopy market worth $12.06B in 2024 and projected to hit $18.79B by 2032 (5.8% CAGR), Surgical Automations is chasing both impact & opportunity. The company’s next milestones, pre-clinical validation, first-in-human trials, and regulatory submissions, are where precision turns to proof.
Dr. Fred Moll and Ganesh Raju didn’t just invest, they co-signed the future. Surgical Automations may still be in stealth mode, but the message is loud: the next revolution in surgical robotics isn’t coming from the spotlight. It’s being engineered quietly in Dallas, ready to move when the world finally catches up.
